NewsRx

Search our medical news database

Rehabilitation Medicine

Spaulding Rehabilitation joins BrainGate Neural Interface System pilot study

Published in Medical Letter on the CDC and FDA, January 9th, 2005

The Spaulding Rehabilitation Hospital (Spaulding) and Cyberkinetics Neurotechnology Systems, Inc. (CYKN) announced the addition of Spaulding as a new clinical site for the BrainGate Neural Interface System pilot study.

Spaulding, a teaching affiliate of Harvard Medical School, is a premier rehabilitation facility in the United States and the second rehabilitation center to participate in the study.

Cyberkinetics received regulatory clearance from the U.S. Food and Drug Administration (FDA) in March of 2004 to study the BrainGate Neural Interface System under an Investigational Device Exemption (IDE).

In the first several weeks of...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook